Recursion Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $712k | 72k | 9.86 |
| 2023-09-30 | $552k | 72k | 7.65 |
| 2023-06-30 | $539k | 72k | 7.47 |
| 2023-03-31 | $481k | 72k | 6.67 |
| 2022-12-31 | $556k | 72k | 7.71 |
| 2022-09-30 | $768k | 72k | 10.64 |
| 2022-06-30 | $587k | 72k | 8.14 |
| 2022-03-31 | $459k | 64k | 7.16 |
| 2021-12-31 | $706k | 41k | 17.13 |
| 2021-09-30 | $247k | 11k | 23.01 |
| 2021-06-30 | $318k | 8.7k | 36.50 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors